Skip to content
lifestyle.lamora.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
AbbVie
AbbVie Declares Quarterly Dividend
September 10, 2026
AbbVie Extends Migraine Leadership with Positive Phase 3 Atogepant Results in Menstrual Migraine
September 10, 2026
AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma
September 3, 2026
AbbVie Completes Acquisition of Apogee Therapeutics
September 3, 2026
AbbVie to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
September 3, 2026
Allergan Aesthetics Unveils the Layered Beauty Report, Advancing the Global Conversation Around Aesthetic Care
September 2, 2026
SkinMedica® Adds Barrier Calming Cream to its Collection of Regenerative Skincare Offerings
September 1, 2026
AbbVie to Present at the Wells Fargo 21st Annual Healthcare Conference
August 31, 2026
AbbVie Submits Regulatory Application to EMA for SKYRIZI® (risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn’s Disease
August 27, 2026
AbbVie to Present New Data at WCLC 2026 Showcasing Innovation Across Lung Cancer Pipeline
August 21, 2026
1
2
3
4
Next Page
→